Mydecine Innovations Group Inc. (FRA:0NF0)
Germany · Delayed Price · Currency is EUR 0.1500
0.00 (0.00%)
Last updated: Nov 21, 2025, 8:00 AM CET
FRA:0NF0 Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
102.35K EUR
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.49K | 4.88K | 186.32% |
| Dec 31, 2020 | 2.62K | -122.96K | -97.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Mydecine Innovations Group News
- 6 weeks ago - CSE Bulletin: Consolidation - Mydecine Innovations Group Inc. (MYCO) - Newsfile Corp
- 6 weeks ago - Mydecine Innovations Group Closes Debt Settlements - TheNewswire
- 2 months ago - Mydecine Innovations Group Announces Results Of Shareholder Meeting And Provides Corporate Update - TheNewswire
- 5 months ago - Mydecine Innovations Group Provides Update On Annual Financial Statements - TheNewswire
- 6 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 7 months ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 8 months ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire